A random-amplified polymorphic DNA assay using partially degenerate oligonucleotides as primers was used for the characterization of 78 epidemiologically related and unrelated clinical isolates of Streptococcus agalactiae belonging to different serotypes. Thirty distinct amplification profiles were obtained among 52 unrelated S. agalactiae isolates assigned to nine groups by serotyping (including 3 nontypeable strains), uncovering the extent of genomic heterogeneity existent within serotypes. This method was particularly useful in providing evidence for or against vertical transmission of a given clone of this microorganism, as well as for relapsing or reinfection in related cases, and suggested clonal relatedness between unrelated S. agalactiae isolates associated with some invasive infections. Thus, this simple methodology represents a suitable tool for the epidemiologic study of S. agalactiae infections.
Streptococcus agalactiae (group B streptococci, GBS) represimplicity, have emerged as methods of choice in the genotypic analysis of organisms [11 -15] . Nevertheless, the identification sents an important cause of morbidity and mortality among peripartum women and newborn infants, increasingly associof appropriate primers to differentiate isolates of a given organism may represent a difficulty [11 -13] . This situation applies ated with invasive disease in adults [1 -3] . GBS isolates are commonly characterized by serotyping, although the relatively to GBS [16] , which seemingly represents a rather refractory organism to characterize by amplification techniques. Since low discriminatory power of this methodology and the existence of nontypeable strains represent disadvantages for epidedegenerate oligonucleotides allow the simultaneous searching of a number of potentially useful primers, the process of screenmiologic studies [4 -6] . Recently, molecular approaches aimed at uncovering the genomic diversity between closely related ing may be substantially simplified [17, 18] . In this context, we reported previously the usefulness of a partially degenerate organisms have been introduced for the analysis of GBS. These include restriction enzyme fragment length polymorphism oligonucleotide as an amplification primer to distinguish among GBS isolates [17] . (RFLP) analysis, ribotyping, pulsed-field gel electrophoresis (PFGE), and multilocus enzyme electrophoresis [3 -10] . HowIn this work we have systematically evaluated the use of a number of different degenerate oligonucleotides and amplificaever, these techniques possess some drawbacks for the field characterization of GBS isolates. RFLP analysis generates comtion conditions for the genomic analysis of a much larger collection of GBS clinical isolates. This degenerate oligonucleoplex banding patterns that are difficult to analyze when the comparison of a large number of strains is intended [4 -6, 9, tide -primed amplification methodology allowed us to uncover the extent of genetic heterogeneity among clinical isolates of 11]. Ribotyping was shown to possess a lower discriminatory power than RFLP analysis or PFGE for the characterization of GBS in our area. GBS [3, 4, 7] . In turn, PFGE and multilocus enzyme electrophoresis, albeit discriminatory approaches [3, 6, 10] , are timeMaterials and Methods consuming and labor-intensive methodologies, which restricts their use to reference laboratories [8, 10 -12] .
Bacterial strains. The sources and serotypes of 78 GBS isolates studied herein are summarized in table 1. All isolates were Techniques based on the random amplification of polymoridentified as S. agalactiae by standard biochemical methods [19, phic DNA (RAPD), due to their discriminatory power and 20] and characterized by group-specific (Oxoid Streptococcal Grouping Kit; Oxoid, Basingstoke, UK) and type-specific (Denka Seiken, Tokyo) agglutination [21, 22] . From these strains, epidemiologically related isolates corresponded to six mother-infant pairs follows. For a high-stringency amplification, after 5 min of dena- into account for the differentiation of isolates. ‡ NT: nontypeable. RAPD, random-amplified polymorphic DNA.
Discriminatory index. The index of discriminatory power (D) was calculated as described [28] .
tinction of the genomic diversity between clinical isolates of Results and Discussion S. agalactiae by random amplification of DNA proved rather refractory, in our hands, when a number of nondegenerate oliEvaluation of different partially degenerate oligonucleotides as primers for the characterization of GBS isolates. The disgonucleotides were used as primers. Since we observed that a partially degenerate oligonucleotide may be particularly suitwere obtained, no marked differences were observed within serotypes. Indeed, its discriminatory power (D: 0.85) was simiable for this purpose [17], we evaluated the use of different degenerate primers and amplification conditions for the characlar to that of serotyping (D: 0.84). Primers 19, 5314, and PS20 provided amplification profiles that allowed distinction both terization of a much larger GBS sample. Fifteen partially degenerate oligonucleotides of variable length (from 28 to 10 between and within serotypes (table 2) . From these primers, 19 provided the best discrimination between isolates from a mers) and degeneracy (from 32,768 to 2 possible sequences) were tested by use of the low-stringency protocol. From them, given serotype, a situation reflected in their corresponding discriminatory powers (table 2) . For instance, 9 isolates of differonly 6 were found to generate amplification profiles of more than three bands, although their discriminatory power was ent serotypes (Ia, II, and V), which generated 9 RAPD patterns with primer 19 (figure 1), produced 6 or 7 profiles with primers highly variable (table 2) . For instance, primers 28 and 20 provided discernible and reproducible patterns, but the profiles PS20 or 5314, respectively (figure 2). Since oligonucleotide 19 appeared as the most suitable were identical for all serotypes (not shown). For primer 24, although distinct profiles between different GBS serotypes primer for the characterization of GBS isolates, we evaluated the effects of reducing its length from either the 3 or 5 end primer 19 for the differentiation of 78 GBS clinical isolates obtained in our area. These isolates were assigned to 9 different on the rationale that a larger number of genome sites would be theoretically available for a shorter primer [29] . Interestgroups by serotyping (Ia, Ia/c, Ib, Ib/c, II, III, IV, V, and 3 nontypeable strains; table 1). From them, 41 were epidemiologingly, the removal of 5 or 9 nucleotides from the 3 end (oligonucleotides 14 and 10, respectively) abolished the capability ically unrelated. Another 37 strains were obtained from 11 different related cases (table 1) . After amplification with primer of the resulting primers to distinguish between isolates (table  2) . This may result from the subsequent reduction in the number 19, 30 distinct RAPD patterns were obtained, each comprising 3 -10 amplification fragments that ranged from 200 to 2000 of potential primers (e.g., oligonucleotide 10 is composed of only two sequences) or, alternatively, the 3 end of primer bp (figure 1). Identical patterns were found in strains isolated from differ-19 might be particularly suitable for disclosing the genomic heterogeneity among GBS isolates. Thus, we studied the effects ent mother-infant pairs (M-I, rows 1, 2, 5, 18, 21, and 28, table 1), strongly suggesting mother-to-infant vertical transmission. of reducing primer 19 from its 5 end. Unexpectedly, the removal of 5 or 9 nucleotides from this end (oligonucleotides Persistent infection by a given GBS clone or reinfection by a different GBS clone was analyzed by comparing RAPD pat-14N and 10N, respectively) markedly reduced not only the total number of amplification bands (not shown) but also the terns of isolates obtained from the same patient at different dates. For instance, isolates 521, 698, 864, 929, 103, and 849, discriminatory capability of the resulting primers (table 2) . Although an overall explanation for these effects is difficult at obtained from the vagina of the same woman at distant dates, showed not only an identical serotype but also the same RAPD present, both the 5 and 3 ends of primer 19, among other factors [29] , seemingly contribute to define its discriminatory pattern (row 18, figure 1 ). On the other hand, reinfection was observed by seroprimer to discriminate between GBS isolates.
Other partially degenerate oligonucleotides tested (i.e., type III isolate 574 obtained from this patient, as judged from its distinct RAPD profile (row 20, table 1; figure 1 ). Reinfection 894, 896, 897, and 898), described as general amplification primers for genome analysis [26, 27] , provided very weak was also found for serotype III isolates 294 and 325 from another patient (rows 23 and 24, table 1; figure 1 ). In turn, the profiles and a null discriminatory power for all unrelated GBS strains ( figure 1 ). fication assay allowed us to recognize genomic differences 365 -73. between GBS isolates of a given serotype (table 1; figure 1 ).
